434
Views
10
CrossRef citations to date
0
Altmetric
Original Articles

Coumestrol ameliorates doxorubicin-induced cardiotoxicity via activating AMPKα

, , , &
Pages 629-639 | Received 22 Jul 2020, Accepted 08 Sep 2020, Published online: 23 Sep 2020
 

Abstract

Doxorubicin (DOX) acts as the cornerstone in multiple tumour chemotherapy regimens, however, its clinical application is often impeded due to the induction of a severe cardiotoxicity that eventually provokes left ventricular dysfunction and congestive heart failure. Coumestrol (CMT) is a common dietary phytoestrogen with pleiotropic pharmacological effects. The present study aims to investigate the role and mechanism of CMT on DOX-induced cardiotoxicity. Mice were intragastrically administrated with CMT (5 mg/kg/day) for consecutive 2 weeks and then received a single intraperitoneal injection of DOX (15 mg/kg) to mimic the clinical toxic effects after 8-day additional feeding. To verify the role of 5′ AMP-activated protein kinase alpha (AMPKα), AMPKα2 global knockout mice were used. H9C2 cells were cultured to further validate the beneficial role of CMT in vitro. CMT administration notably ameliorated oxidative damage, cell apoptosis and cardiac dysfunction in DOX-treated mice. Besides, we observed that DOX-induced reactive oxygen species overproduction and cardiomyocyte apoptosis were also reduced by CMT incubation in H9C2 cells. Mechanistically, CMT activated AMPKα and Ampkα deficiency abolished the beneficial effects of CMT in vivo and in vitro. Finally, we proved that protein kinase A (PKA) was required for CMT-mediated AMPKα activation and cardioprotective effects. CMT activated PKA/AMPKα pathway to alleviate DOX-induced oxidative damage, cell apoptosis and cardiac dysfunction. Our findings provide a promising therapeutic agent for cancer patients receiving anthracycline chemotherapy.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Data availability

All data that support the findings in this study are available from the corresponding author upon reasonable request.

Additional information

Funding

This work was supported by grants from the Key Project of the National Natural Science Foundation [No. 81530012], the Fundamental Research Funds for the Central Universities [2042018kf1032], National Key R&D Program of China [2018YFC1311300], Development Center for Medical Science and Technology National Health and Family Planning Commission of the People’s Republic of China [The prevention and control project of cardiovascular disease, 2016ZX-008-01] and Science and Technology Planning Projects of Wuhan [2018061005132295].
This work was supported by grants from the Key Project of the National Natural Science Foundation [No. 81530012], the Fundamental Research Funds for the Central Universities [2042018kf1032], National Key R&D Program of China [2018YFC1311300], Development Center for Medical Science and Technology National Health and Family Planning Commission of the People’s Republic of China [The prevention and control project of cardiovascular disease, 2016ZX-008-01] and Science and Technology Planning Projects of Wuhan [2018061005132295].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.